Femara 2.5 mg by Unique Pharma

Femara (Letrozole) 2.5 mg by Unique Pharma is a powerful aromatase inhibitor (AI) designed to significantly reduce estrogen levels. Commonly used in medical settings for hormone-sensitive breast cancer treatment, it is also used by athletes and enhanced-performance users to control estrogen-related side effects during anabolic steroid cycles. With a short 2-hour half-life, Letrozole delivers rapid hormonal modulation.

Available in 100 oral tablets at www.cartelunited.eu.

Uses

• Reducing estrogen production

• Supporting hormone therapy in estrogen-sensitive conditions

• Managing estrogenic side effects during AAS use (water retention, gynecomastia)

• Maintaining a leaner, drier physique during cycles

• Preventing estrogen rebound when transitioning off aromatizing compounds

Effects

• Strong suppression of aromatase enzyme activity

• Reduced risk of estrogenic side effects

• More defined, harder muscle appearance due to lower water retention

• Stabilized hormonal environment during anabolic cycles

• Therapeutic benefit for hormone receptor–positive breast cancer (medical use)

Side Effects

Bone & Musculoskeletal

• Reduced bone mineral density

• Joint or muscle pain

Hormonal & Metabolic

• Significant estrogen suppression

• Increased cholesterol levels

General

• Hot flashes

• Fatigue

• Headaches

• Possible cardiovascular strain

Other

• Vaginal dryness (in women)

• Rare vision changes

Dosage Guidance

• Typical weekly use in enhanced-hormone environments: 2.5–17.5 mg per week, depending on individual estrogen levels and cycle intensity.

• Due to the strong potency, dosing must be conservative and adjusted carefully.

• Medical dosage (breast cancer treatment): 2.5 mg daily.
  (Exact medical dosing should always follow licensed healthcare guidance.)

Combinations / Stacking

Femara may be paired with:

• AAS cycles requiring high-level estrogen control

• Testosterone (to balance hormonal ratios)

• Bone-support supplements (calcium, vitamin D)

• Cardiovascular support

• SERMs (for post-cycle therapy, depending on protocol)